Patent Assignment
Reel/Frame 059813/0073
Assignment of Assignor's Interest
Recorded: 2022-05-04
Pages: 4
Assignor
MCKEAN, ROBERT
Executed: 2022-05-04
Assignee
MINERALYS THERAPEUTICS, INC.
150 N. RADNOR CHESTER RD., SUITE F200, RADNOR, PENNSYLVANIA, 19087
Covered Property
(1)
Soluble Pharmaceutical Compositions Comprising Salts of Disubstituted 1, 2, 4-Triazine Compound
Application:
63/223,711 →
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 4, 2022
From: OHASHI, YOSHINORI; OZAKI, FUMINORI; OHSHIMA, HIROKI; NAGATA, HIROOMI
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 059813/0060 →
Change of Name
May 28, 2026
From: MITSUBISHI TANABE PHARMA CORPORATION
To: TANABE PHARMA CORPORATION
Reel/Frame 075642/0567 →
Patent Security Agreement
Jun 3, 2026
From: MINERALYS THERAPEUTICS, INC.
To: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
Reel/Frame 075769/0102 →